1.07
0.00 (0.00%)
| Penutupan Terdahulu | 1.07 |
| Buka | 1.03 |
| Jumlah Dagangan | 1,885,281 |
| Purata Dagangan (3B) | 1,968,249 |
| Modal Pasaran | 405,515,008 |
| Harga / Jualan (P/S) | 2.29 |
| Harga / Buku (P/B) | 0.910 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2025 - 12 May 2025 |
| Margin Keuntungan | -79.62% |
| Margin Operasi (TTM) | -29.42% |
| EPS Cair (TTM) | -0.520 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -14.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 118.03% |
| Nisbah Semasa (MRQ) | 5.70 |
| Aliran Tunai Operasi (OCF TTM) | -143.45 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -71.55 M |
| Pulangan Atas Aset (ROA TTM) | -18.01% |
| Pulangan Atas Ekuiti (ROE TTM) | -43.75% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Standard BioTools Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.88 |
|
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.86% |
| % Dimiliki oleh Institusi | 73.11% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Hollow Brook Wealth Management Llc | 30 Sep 2024 | 5,532,951 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 30 May 2025 | Pengumuman | Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series |
| 06 May 2025 | Pengumuman | Standard BioTools Reports First Quarter 2025 Financial Results |
| 24 Apr 2025 | Pengumuman | Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 |
| 22 Apr 2025 | Pengumuman | Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |